Solvonis Therapeutics plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
Solvonis Therapeutics plc is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.
Not all Walbrook clients have a handy 2 page summary available. Click
on "Register your interest" and we'll let the Company know that you
think this would be useful
Latest Company Summary
Investor Access
Event information
Venue
Time
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
